About Aalto Bio Reagents
Aalto Bio Reagents is a company based in Dublin (Ireland) founded in 1978 was acquired by Biosynth Carbosynth in May 2022.. Aalto Bio Reagents offers products and services including Recombinant Antigens, Monoclonal Antibodies, Bulk Antigens, and Disease State Plasma. Aalto Bio Reagents operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aalto Bio Reagents Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aalto Bio Reagents
Aalto Bio Reagents offers a comprehensive portfolio of products and services, including Recombinant Antigens, Monoclonal Antibodies, Bulk Antigens, and Disease State Plasma. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Custom manufactured antigens for disease testing and research
Antibodies used in diagnostics for human and veterinary diseases
Routine antigens for chemiluminescence platforms and controls
Plasma for diagnostic controls and testing purposes
Funding Insights of Aalto Bio Reagents
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aalto Bio Reagents
Aalto Bio Reagents has secured backing from 1 investor. Prominent investors backing the company include Biosynth Carbosynth. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug discovery, manufacturing, supply chain, regulatory support, and other services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aalto Bio Reagents
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aalto Bio Reagents
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aalto Bio Reagents Comparisons
Competitors of Aalto Bio Reagents
Aalto Bio Reagents operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies for the treatment of multiple diseases
|
|
| domain | founded_year | HQ Location |
Antibodies and immunoassay kits are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Antibody and vaccine culture media products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aalto Bio Reagents
Frequently Asked Questions about Aalto Bio Reagents
When was Aalto Bio Reagents founded?
Aalto Bio Reagents was founded in 1978.
Where is Aalto Bio Reagents located?
Aalto Bio Reagents is headquartered in Dublin, Ireland.
What does Aalto Bio Reagents do?
Founded in 1978 in Dublin, Ireland, Aalto Bio Reagents operates in the in-vitro diagnostics sector. Raw materials such as purified human proteins, monoclonal and polyclonal antibodies, fungal, parasitic, bacterial, and viral antigens, and disease state plasma are developed, manufactured, and marketed for diagnostic applications and research. DIY assay protocols for HIV-1-p24gag and HIV-1 gp120 env are offered to AIDS research labs. Molecular controls for the IVD industry are under development.
Who are the top competitors of Aalto Bio Reagents?
Aalto Bio Reagents's top competitors include Sino Biological, GenScript and Y-Biologics.
What products or services does Aalto Bio Reagents offer?
Aalto Bio Reagents offers Recombinant Antigens, Monoclonal Antibodies, Bulk Antigens, and Disease State Plasma.
Who are Aalto Bio Reagents's investors?
Aalto Bio Reagents has 1 investor. Key investors include Biosynth Carbosynth.